Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

NCT04045665 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT04045665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04045665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Phase 3
Overall status
Recruiting
Start date
December 13, 2019
Completion date
August 31, 2026
Enrollment
3,200 (estimated)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, bleeding, stroke